CRIS Q1 2022 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-6.0% YoY

Gross Profit

$2M96.0% margin

Operating Income

-$15M-735.7% margin

Net Income

-$16M-783.1% margin

EPS (Diluted)

$-3.52

QoQ Revenue Growth

-34.4%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$141M

Total Liabilities

$65M

Stockholders' Equity

$76M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-6.0%
Gross Profit	$2M	$2M	-5.0%
Operating Income	-$15M	-$9M	-72.0%
Net Income	-$16M	-$10M	-62.3%

Revenue Segments

Gross Royalty Revenue

$2M100%

Contra Revenue

-$3,000-0%